Market Overview

According to fortune business insights, The global intraocular lens (IOL) market size was valued at USD 5.14 billion in 2025. The market is projected to grow from USD 5.49 billion in 2026 to USD 9.52 billion by 2034, exhibiting a CAGR of 7.13% during the forecast period. North America dominated the intraocular lens market with a market share of 33.76% in 2025.

The analysis shows that intraocular lenses—artificial lenses implanted in the eye during cataract and glaucoma surgeries—are experiencing strong demand due to the rising global prevalence of cataracts. According to the WHO, an estimated 94.0 million people suffer from cataracts globally, with a massive unmet need for surgical intervention. Advanced product launches, coupled with rising government support and favorable reimbursement policies to decrease surgery backlogs, are significantly contributing to market growth.

Major Players Profiled in the Market Report:

• Alcon Inc. (Switzerland)
• Johnson & Johnson Vision Care, Inc. and Johnson & Johnson Surgical Vision, Inc. (U.S.)
• Bausch & Lomb Incorporated (Canada)
• HOYA (Japan)
• STAAR SURGICAL (U.S.)
• Rayner Intraocular Lenses Limited. (U.K.)
• Hanita Lenses (Israel)
• SIFI S.p.A (Italy)
• Biotech (Switzerland)

Segments

Affordability of Monofocal Lenses Boosted Segment Growth

Based on type, the market is segmented into monofocal and premium (multifocal, toric, and others). The monofocal segment holds the dominant market share (projected at 64.41% in 2026). This is because monofocal lenses are cheaper than premium alternatives, widely used in government-led cataract surgery initiatives, and benefit from more favorable reimbursement policies.

High Demand for Hydrophobic Acrylic Products Favors the Foldable Segment’s Dominance

By material, the market is divided into polymethylmethacrylate (PMMA) and foldable (hydrophobic acrylic, hydrophilic acrylic, and silicone & collamer). The foldable segment is dominating the market with a projected share of 87.59% in 2026 due to its high refractive index, low water content, and ability to be inserted through small surgical incisions.

Favorable Government Policies to Drive the Growth of Hospitals & Ambulatory Surgery Centers

Based on end-user, the market is segmented into hospitals & ambulatory surgery centers, specialty clinics, and academic & research institutes. The hospitals & ambulatory surgery centers segment dominates the market (projected at 57.42% in 2026) as they are the primary care centers for cataract procedures, supported by special government drives to clear surgery backlogs.